Prophylaxe der kaninen Parvovirose

Zusammenfassung

Obwohl Impfstoffe gegen das canine Parvovirus (CPV) weltweit eingesetzt werden, tritt die Parvovirose vor allem bei jungen Hunden nach wie vor vergleichsweise häufig auf. Der vorliegende Übersichtsartikel konzentriert sich auf die Ursachen für ein Impfversagen. Hierfür kommen unterschiedlichste Faktoren in Betracht, die den Hund selbst oder seine Umwelt betreffen. So gibt es genetisch bedingt Hunde, die keine Antikörper (Non-Responder) oder nur sehr niedrige Konzentrationen an Antikörpern (Low-Responder) nach einer CPV-Impfung ausbilden. Der Impferfolg kann auch durch andere intrinsische Faktoren (z. B. Gewicht, Alter, Reproduktions- und Ernährungsstatus, Krankheiten) und/oder extrinsische Faktoren (z. B. Stress, Belastung, Medikamente) beeinträchtigt werden. Neben Ursachen, die den individuellen Hund betreffen, kann ein Impfversagen auch durch eine reduzierte immunisierende Eigenschaft des Impfstoffs bedingt sein; hierfür kommt eine Vielzahl verschiedener Faktoren in Betracht (z. B. Herstellung, Lagerung, Applikation).

Abstract

Although vaccines against canine parvovirus (CPV) are used worldwide, CPV infection still occurs relatively commonly, mainly in young dogs. This review article focuses on different causes of vaccination failures. Various factors affecting the dog itself or its environment can be responsible. A subset of dogs fail to develop antibodies (non-responders) or produce only very low antibody titers (low-responders) following vaccination against CPV for genetic reasons. In addition, vaccination efficacy can be affected by other intrinsic factors (e. g., weight, age, reproductive, and nutritional status, diseases) and/or extrinsic factors (e. g., stress, physical strain, medications). In addition to these causes affecting the individual dog, vaccine failure can also be caused by reduced immunizing properties of the vaccine itself. A variety of different factors (e. g., manufacturing, storage, application) can be responsible for this effect.

Schlüsselwörter

CPV - Hund - Schutz - Immunität - Impfung - Vakzine - MLV - Non-Responder

Key words

CPV - dog - protection - immunity - vaccination - vaccine - MLV - non-responder

Publication History

Received: 18 March 2022

Accepted: 24 June 2022

Article published online:
02 November 2022

• Literatur

• 1 Roth JA. Mechanistic bases for adverse vaccine reactions and vaccine failures, in: Adverse vaccine reactions, failures, and postmarketing surveillance. In: Schultz RD. Advances in Veterinary Medicine, Volume 41, Veterinary Vaccines and Diagnostics. San Diego, Kalifornien, USA: Academic Press; 1999: 681-700
• 2 Meyer EK. Vaccine-associated adverse events. Vet Clin North Am Small Anim Pract 2001; 31: 493-514 DOI: 10.1016/S0195-5616(01)50604-X.
• 3 Day MJ. Vaccine side effects: Fact and fiction. Vet Microbiol 2006; 117: 51-58 DOI: 10.1016/j.vetmic.2006.04.017.
• 4 Hoffmann A, Mergel A, Cußler K. Pharmakovigilanzreport Tierimpfstoffe. Zur Statistik der im Jahr 2006 im Paul-Ehrlich-Institut eingegangenen Meldungen. DTBI 2007; 12: 1536-1539
• 5 Tizard IR. The use of vaccines. In: Tizard IR. Veterinary Immunology. 10th. Aufl. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 274-284
• 6 StIKo Vet am FLI. Leitlinie zur Impfung von Kleintieren. 5. Auflage. 2021: 1-187
• 7 Day MJ, Horzinek MC, Schultz RD. et al. WSAVA Guidelines for the vaccination of dogs and cats. J Small Anim Pract 2016; 57: E1-e45 DOI: 10.1111/jsap.2_12431.
• 8 Dyer F, Spagnuolo-Weaver M. Efficacy of vaccination against canine parvovirus. Vet Rec 2006; 159: 605 DOI: 10.1136/vr.159.18.605-a.
• 9 Ilott M. Efficacy of vaccination against canine parvovirus. Vet Rec 2006; 159: 722-723 DOI: 10.1136/vr.159.21.722-d.
• 10 Thompson H. Efficacy of vaccination against canine parvovirus. Vet Rec 2006; 159: 570-571 DOI: 10.1136/vr.159.17.570-b.
• 11 Dyer F, Spagnuolo-Weaver M, Cooles S. et al. Suspected adverse reactions, 2006. Vet Rec 2007; 160: 748-750 DOI: 10.1136/vr.160.22.748.
• 12 Paul MA, Carmichael LE, Childers H. et al. 2006 AAHA canine vaccine guidelines. J Am Anim Hosp Assoc 2006; 42: 80-89 DOI: 10.5326/0420080.
• 13 Norris JM, Krockenberger MB, Baird AA. et al. Canine distemper: Re-emergence of an old enemy. Aust Vet J 2006; 84: 362-363 DOI: 10.1111/j.1751-0813.2006.00032.x.
• 14 Day MJ. Vaccine safety in the neonatal period. J Comp Pathol 2007; 137: 51-56 DOI: 10.1016/j.jcpa.2007.04.019.
• 15 Bertolizio G, Astuto M, Ingelmo P. The implications of immunization in the daily practice of pediatric anesthesia. Curr Opin Anaesthesiol 2017; 30: 368-375 DOI: 10.1097/aco.0000000000000462.
• 16 Decaro N, Desario C, Addie DD. et al. Molecular epidemiology of canine parvovirus, Europe. Emerg Infect Dis 2007; 13: 1222-1224 DOI: 10.3201/eid1308.070505.
• 17 Greene CE, Levy J. Immunoprophylaxis. In: Greene CE. Infectious Diseases of the Dog and Cat. 4. Aufl.. St. Louis, Missouri, USA: Saunders Elsevier; 2012: 1163-1205
• 18 Sykes JE. Immunization. In: Sykes JE. Canine and Feline Infectious Diseases. 1. Aufl.. St. Louis, Missouri, USA: Elsevier Saunders; 2014: 119-130 DOI: 10.1016/B978–1-4377–0795–3.00012–0
• 19 Roth JA, Spickler AR. Duration of immunity induced by companion animal vaccines. Anim Health Res Rev 2010; 11: 165-190 DOI: 10.1017/s1466252310000150.
• 20 Muneer MA, Farah IO, Newman JA. et al. Immunosuppression in animals. Brit Vet J 1988; 144: 288-301 DOI: 10.1016/0007-1935(88)90116-9.
• 21 Povey RC, Carman PS. Factors influencing the outcome of vaccination. In: Pastoret PP, Blancou J, Vannier P. et al Veterinary Vaccinology. Amsterdam, Niederlande: Elsevier Science B. V.; 1997: 540-545
• 22 Scherk M. Vaccination and the immune status of the cat. 33 rd Congress of the World Small Animal Veterinary Association (WSAVA). 2008 Online im Internet: https://www.vin.com/apputil/content/defaultadv1.aspx?pId=11268&meta=generic&id=3866715;27.05.2019
• 23 Nolte I. Erkrankungen des Immunsystems. In: Kohn B, Schwarz G. Praktikum der Hundeklinik. 12. Aufl.. Stuttgart, Deutschland: Enke Verlag; 2018: 323-341 DOI: 10.1055/b-0037–147285
• 24 Day MJ, Schultz RD. The biology of B lymphocytes. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 113-124
• 25 Day MJ, Schultz RD. Immune suppression. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 131-138
• 26 Tizard IR. Dendritic cells and antigen processing. In: Tizard IR. Veterinary Immunology. 10. Aufl.. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 89-99
• 27 Tizard IR. The major histocompatibility complex. In: Tizard IR. Veterinary Immunology. 10th. Aufl.. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 100-107
• 28 Kennedy LJ, Carter SD, Barnes A. et al. Interbreed variation of DLA-DRB1, DQA1 alleles and haplotypes in the dog. Vet Immunol Immunopathol 1999; 69: 101-111
• 29 Kennedy LJ, Carter SD, Barnes A. et al. DLA-DRB1 polymorphisms in dogs defined by sequence-specific oligonucleotide probes (SSOP). Tissue antigens 1999; 53: 184-189
• 30 Kennedy LJ, Barnes A, Happ GM. et al. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue antigens 2002; 59: 194-204
• 31 Kennedy LJ, Barnes A, Happ GM. et al. Evidence for extensive DLA polymorphism in different dog populations. Tissue antigens 2002; 60: 43-52
• 32 Kennedy LJ, Lunt M, Barnes A. et al Do dogs vary in their response to rabies vaccination? 48th Congress of the British Small Animal Veterinary Association (BSAVA). 2005: 550
• 33 Kennedy LJ, Lunt M, Barnes A. et al. Factors influencing the antibody response of dogs vaccinated against rabies. Vaccine 2007; 25: 8500-8507 DOI: 10.1016/j.vaccine.2007.10.015.
• 34 Wallace RM, Pees A, Blanton JB. et al. Risk factors for inadequate antibody response to primary rabies vaccination in dogs under one year of age. PLoS Negl Trop Dis 2017; 11: e0005761 DOI: 10.1371/journal.pntd.0005761.
• 35 Larson LJ, Schultz RD. Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine. Vet Ther 2007; 8: 305-310
• 36 Riedl M, Truyen U, Reese S. et al. Prevalence of antibodies to canine parvovirus and reaction to vaccination in client-owned, healthy dogs. Vet Rec 2015; 177: 597 DOI: 10.1136/vr.103271.
• 37 Glickman LT, Domanski LM, Patronek GJ. et al. Breed-related risk factors for canine parvovirus enteritis. J Am Vet Med Assoc 1985; 187: 589-594
• 38 Houston DM, Ribble CS, Head LL. Risk factors associated with parvovirus enteritis in dogs: 283 cases (1982–1991). J Am Vet Med Assoc 1996; 208: 542-546
• 39 Greene CE, Schultz RD, Ford RB. Canine vaccination. Vet Clin North Am Small Anim Pract 2001; 31: 473-492 , v-vi
• 40 Ford RB, Larson LJ, McClure KD. et al. 2017 AAHA Canine Vaccination Guidelines. J Am Anim Hosp Assoc 2017; 53: 243-251 DOI: 10.5326/jaaha-ms-6741.
• 41 Schultz RD. Theory and practice of immunization, in: Small animal immunology: New faces of immune-mediated diseases and current concepts in vaccine immunology. In, San Diego County Spring Veterinary Conference. San Diego, Kalifornien, USA; 1995: 82-99
• 42 Schultz RD. Canine vaccines and immunity: Important considerations in the success of vaccination programms. San Diego County Spring Veterinary Conference; 1995: 100-113
• 43 Abdelmagid OY, Larson L, Payne L. et al. Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges. Vet Ther 2004; 5: 173-186
• 44 Burr P. Serological testing—an alternative to boosters?. Vet Microbiol 2006; 117: 39-42 DOI: 10.1016/j.vetmic.2006.04.008.
• 45 Saalmüller A. New understanding of immunological mechanisms. Vet Microbiol 2006; 117: 32-38 DOI: 10.1016/j.vetmic.2006.04.007.
• 46 Böhm M. Current vaccination strategies in dogs and cats. In Pract 2009; 31: 2-7 DOI: 10.1136/inpract.31.1.2.
• 47 Taguchi M, Namikawa K, Maruo T. et al. Antibody titers for canine parvovirus type-2, canine distemper virus, and canine adenovirus type-1 in adult household dogs. Can Vet J 2011; 52: 983-986
• 48 Killey R, Mynors C, Pearce R. et al. Long-lived immunity to canine core vaccine antigens in UK dogs as assessed by an in-practice test kit. J Small Anim Pract 2018; 59: 27-31 DOI: 10.1111/jsap.12775.
• 49 Day MJ, Schultz RD. Immune system ontogeny and neonatal immunology. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 213-220
• 50 Day MJ, Schultz RD. Immunodeficiency. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 221-231
• 51 Debenham SL, Millington A, Kijast J. et al. Canine leucocyte adhesion deficiency in Irish Red and White Setters. J Small Anim Prac t 2002; 43: 74-75
• 52 Foureman P, Whiteley M, Giger U. Canine leukocyte adhesion deficiency: Presence of the Cys36Ser beta-2 integrin mutation in an affected US Irish Setter cross-breed dog and in US Irish Red and White Setters. J Vet Intern Med 2002; 16: 518-523 DOI: 10.1892/0891–6640(2002)016 < 0518:cladpo > 2.3.co;2L42:URLEND.
• 53 Kijas JM, Bauer TR , Jr.,, Gäfvert S. et al. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency. Genomics 1999; 61: 101-107 DOI: 10.1006/geno.1999.5948.
• 54 Pfeiffer I, Brenig B. Frequency of the canine leucocyte adhesion deficiency (CLAD) mutation among Irish Red Setters in Germany. J Anim Breed Genet 2005; 122: 140-142
• 55 Felsburg PJ, Hartnett BJ, Henthorn PS. et al. Canine X-linked severe combined immunodeficiency. Vet Immunol Immunopathol 1999; 69: 127-135
• 56 Somberg RL, Robinson JP, Felsburg PJ. T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency. J Immunol 1994; 153: 4006-4015
• 57 Day MJ. Possible immunodeficiency in related Rottweiler dogs. J Small Anim Pract 1999; 40: 561-568
• 58 Day MJ. Immune system development in the dog and cat. J Comp Pathol 2007; 137: S10-15 DOI: 10.1016/j.jcpa.2007.04.005.
• 59 Generatio GmbH. Erbkrankheiten beim Hund. Online im Internet: Accessed August 03, 2021 at: https://www.centerforanimalgenetics.com/de/leistungen/gentests-fuer-hunde/erbkrankheiten-beim-hund/schwere-kombinierte-immundefizienz-x-chromosomale-xscid/
• 60 Davis UC. Veterinary Genetics Laboratory. Canine Leukocyte Adhesion Deficiency (CLAD) in German Shepherd Dogs. Online im Internet: Accessed August 03, 2021 at: https://vgl.ucdavis.edu/test/clad-gs
• 61 S IKo Vet am FLI. Stellungnahme zur Impfung von immunsupprimierten und alten Patienten in der Kleintierpraxis. 2017: 1-15
• 62 Decaro N, Buonavoglia C, Barrs VR. Canine parvovirus vaccination and immunisation failures: Are we far from disease eradication?. Vet Microbiol 2020; 247: 108760 DOI: 10.1016/j.vetmic.2020.108760.
• 63 Shams F, Pourtaghi H, Abdolmaleki Z. The first evaluation of the effectiveness of canine vaccination schedule by two commercial vaccines in Iran. BMC Vet Res 2022; 18: 119 DOI: 10.1186/s12917-022-03219-2.
• 64 Jakel V, Cussler K, Hanschmann KM. et al. Vaccination against feline panleukopenia: Implications from a field study in kittens. BMC Vet Res 2012; 8: 62 DOI: 10.1186/1746-6148-8-62.
• 65 HogenEsch H, Thompson S. Effect of ageing on the immune response of dogs to vaccines. J Comp Pathol 2010; 142: 74-77 DOI: 10.1016/j.jcpa.2009.09.006.
• 66 Ginaldi L, Loreto MF, Corsi MP. et al. Immunosenescence and infectious diseases. Microbes Infect 2001; 3: 851-857
• 67 Dall’Ara P. Immune system and ageing in the dog: Possible consequences and control strategies. Vet Res Commun 2003; 27: 535-542
• 68 Dwivedi P, Burns RB. Effect of ochratoxin A on immunoglobulins in broiler chicks. Res Vet Sci 1984; 36: 117-121
• 69 Mansfield KL, Burr PD, Snodgrass DR. et al. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet Rec 2004; 154: 423-426
• 70 Day MJ, Schultz RD. Vaccination. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 233-247
• 71 Bergmann M, Freisl M, Hartmann K. Prevention of canine parvovirosis – Part 1: Humoral and cellular immunity. Tierarztliche Praxis Ausgabe K 2021; 49: 44-50 DOI: 10.1055/a-1319-4564.
• 72 Taguchi M, Namikawa K, Maruo T. et al. Booster effect of canine distemper, canine parvovirus infection and infectious canine hepatitis combination vaccine in domesticated adult dogs. Microbiol Immunol 2012; 56: 579-582 DOI: 10.1111/j.1348-0421.2012.00475.x.
• 73 Shaw Jr. FE, Guess HA, Roets JM. et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine 1989; 7: 425-430
• 74 Dodds WJ. The immune system and disease resistance. Clin Tech in Small Anim Pract 2002; 17: 58-63
• 75 Schuurs AH, Verheul HA. Effects of gender and sex steroids on the immune response. J Steroid Biochem Mol Biol 1990; 35: 157-172
• 76 Gaillard RC, Spinedi E. Sex- and stress-steroids interactions and the immune system: Evidence for a neuroendocrine-immunological sexual dimorphism. Domest Anim Endocrinol 1998; 15: 345-352
• 77 Tanriverdi F, Silveira LF, MacColl GS. et al. The hypothalamic-pituitary-gonadal axis: Immune function and autoimmunity. J Endocrinol 2003; 176: 293-304 DOI: 10.1677/joe.0.1760293.
• 78 Arredouani MS. New insights into androgenic immune regulation. Oncoimmunology 2014; 3: e954968 DOI: 10.4161/21624011.2014.954968.
• 79 Larkin TA, Ashcroft E, Hickey BA. et al. Influence of gender, BMI and body shape on theoretical injection outcome at the ventrogluteal and dorsogluteal sites. J Clin Nurs 2018; 27: e242-250 DOI: 10.1111/jocn.13923.
• 80 Zaybak A, Güneş UY, Tamsel S. et al. Does obesity prevent the needle from reaching muscle in intramuscular injections?. J Adv Nurs 2007; 58: 552-556 DOI: 10.1111/j.1365-2648.2007.04264.x.
• 81 Greeley EH, Ballam JM, Harrison JM. et al. The influence of age and gender on the immune system: A longitudinal study in Labrador Retriever dogs. Vet Immunol Immunopathol 2001; 82: 57-71
• 82 Corrain R, Di Francesco A, Bolognini M. et al. Serosurvey for CPV-2, distemper virus, ehrlichiosis and leishmaniosis in free-ranging dogs in Italy. Vet Rec 2007; 160: 91-92
• 83 Twark L, Dodds WJ. Clinical use of serum parvovirus and distemper virus antibody titers for determining revaccination strategies in healthy dogs. J Am Vet Med Assoc 2000; 217: 1021-1024
• 84 McCaw DL, Thompson M, Tate D. et al. Serum distemper virus and parvovirus antibody titers among dogs brought to a veterinary hospital for revaccination. J Am Vet Med Assoc 1998; 213: 72-75
• 85 Lechner ES, Crawford PC, Levy JK. et al. Prevalence of protective antibody titers for canine distemper virus and canine parvovirus in dogs entering a Florida animal shelter. J Am Vet Med Assoc 2010; 236: 1317-1321 DOI: 10.2460/javma.236.12.1317.
• 86 Day MJ, Schultz RD. Autoimmunity and autoimmune disease. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Pracitice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 187-199
• 87 Tizard IR. Organ graft rejection and pregnancy. In: Tizard IR. Veterinary Immunology. 10. Aufl. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 377-387
• 88 Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: A new challenging role for regulatory T cells. Placenta 2014; 35: 241-248 DOI: 10.1016/j.placenta.2014.02.004.
• 89 La Rocca C, Carbone F, Longobardi S. et al The immunology of pregnancy: Regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett 2014; 162: 41-48 DOI: 10.1016/j.imlet.2014.06.013.
• 90 Samstein RM, Josefowicz SZ, Arvey A. et al. Extrathymic generation of regulatory T cells in placental mammals mitigates maternal-fetal conflict. Cell 2012; 150: 29-38 DOI: 10.1016/j.cell.2012.05.031.
• 91 Pope RM. Immunoregulatory mechanisms present in the maternal circulation during pregnancy. Baillieres Best Pract Res Clin Rheumatol 1990; 4: 33-52
• 92 Povey RC, Carman PS. Risks of vaccination. In: Pastoret PP, Blancou J, Vannier P. et al Veterinary Vaccinology. Amsterdam, Niederlande: Elsevier Science B. V.; 1997: 546-551
• 93 Glaser R, Kiecolt-Glaser JK. Stress-induced immune dysfunction: Implications for health. Nat Rev Immunol 2005; 5: 243-251 DOI: 10.1038/nri1571.
• 94 Griffin JFT. Stress and immunity: A unifying concept. Vet Immunol Immunopathol 1989; 20: 263-312
• 95 Tizard IR. Regulation of adaptive immunity. In: Tizard IR. Veterinary Immunology. 10. Aufl.. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 207-220
• 96 Pedersen BK, Kappel M, Klokker M. et al. The immune system during exposure to extreme physiologic conditions. Int J Sports Med 1994; 15: S116-121 DOI: 10.1055/s-2007-1021125.
• 97 Mackenzie AM, Drennan M, Rowan TG. et al. Effect of transportation and weaning on humoral immune responses of calves. Res Vet Sci 1997; 63: 227-230
• 98 Cheng HW, Fahey A. Effects of group size and repeated social disruption on the serotonergic and dopaminergic systems in two genetic lines of White Leghorn laying hens. Poult Sci 2009; 88: 2018-2025 DOI: 10.3382/ps.2008-00302.
• 99 Fahey AG, Cheng HW. Effects of social disruption on physical parameters, corticosterone concentrations, and immune system in two genetic lines of White Leghorn layers. Poult Sci 2008; 87: 1947-1954 DOI: 10.3382/ps.2007-00477.
• 100 Fahey AG, Cheng HW. Group size and density effects on physical indices and cell-mediated immunity in two genetic lines of White Leghorn layers. Poult Sci 2008; 87: 2500-2504 DOI: 10.3382/ps.2007-00407.
• 101 Adriaansen-Tennekes R, Decuypere E, Parmentier HK. et al. Chicken lines selected for their primary antibody response to sheep red blood cells show differential hypothalamic-pituitary-adrenal axis responsiveness to mild stressors. Poult Sci 2009; 88: 1879-1882 DOI: 10.3382/ps.2009-00150.
• 102 De Groot J, Ruis MA, Scholten JW. et al. Long-term effects of social stress on antiviral immunity in pigs. Physiol Behav 2001; 73: 145-158 DOI: 10.1016/s0031-9384(01)00472-3.
• 103 Gabriel H, Kindermann W. The acute immune response to exercise: What does it mean?. Int J Sports Med 1997; 18: S28-45 DOI: 10.1055/s-2007-972698.
• 104 Nieman DC. Exercise immunology: Practical applications. Int J Sports Med 1997; 18: S91-100 DOI: 10.1055/s-2007-972705.
• 105 Kurcz EV, Lawrence LM, Kelley KW. et al. The effect of intense exercise on the cell-mediated immune response of horses. Equine Vet J 1988; 8: 237-239 DOI: 10.1016/S0737–0806(88)80015–7.
• 106 Keadle TL, Pourciau SS, Melrose PA. et al. Acute exercises stress modulates immune function in unfit horses. J Equine Vet Sci 1993; 13: 226-231 DOI: 10.1016/S0737–0806(06)81019–1.
• 107 Folsom RW, Littlefield-Chabaud MA, French DD. et al. Exercise alters the immune response to equine influenza virus and increases susceptibility to infection. Equine Vet J 2001; 33: 664-669 DOI: 10.2746/042516401776249417.
• 108 McKenzie EC, Jose-Cunilleras E, Hinchcliff KW. et al. Serum chemistry alterations in Alaskan sled dogs during five successive days of prolonged endurance exercise. J Am Vet Med Assoc 2007; 230: 1486-1492 DOI: 10.2460/javma.230.10.1486.
• 109 Banse HE, McKenzie EC, Nelson S. et al. Assessment of serum antibody titers against canine distemper virus, canine adenovirus type II, and canine parvovirus in Alaskan sled dogs before and after a long-distance race. J Am Vet Med Assoc 2008; 232: 1669-1673 DOI: 10.2460/javma.232.11.1669.
• 110 Boonchuvit B, Hamilton PB. Interaction of aflatoxin and paratyphoid infections in broiler chickens. Poult Sci 1975; 54: 1567-1573 DOI: 10.3382/ps.0541567.
• 111 Cheville NF. Environmental factors affecting the immune response of birds: A review. Avian Dis 1979; 23: 308-314
• 112 Shivachandra SB, Sah RL, Singh SD. et al. Immunosuppression in broiler chicks fed aflatoxin and inoculated with fowl adenovirus serotype-4 (FAV-4) associated with hydropericardium syndrome. Vet Res Commun 2003; 27: 39-51
• 113 Koller LD. Immunosuppression produced by lead, cadmium, and mercury. Am J Vet Res 1973; 34: 1457-1458
• 114 Lesourd BM. Nutrition and immunity in the elderly: Modification of immune responses with nutritional treatments. The American journal of clinical nutrition 1997; 66: 478S-484S DOI: 10.1093/ajcn/66.2.478S.
• 115 Griebel PJ, Schoonderwoerd M, Babiuk LA. Ontogeny of the immune response: Effect of protein energy malnutrition in neonatal calves. Can J Vet Res 1987; 51: 428-435
• 116 Tizard IR. The microbiota and the immune system. In: Tizard IR. Veterinary Immunology. 10. Aufl.. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 221-233
• 117 Veir JK, Knorr R, Cavadini C. et al. Effect of supplementation with Enterococcus faecium (SF68) on immune functions in cats. Vet Ther 2007; 8: 229-238
• 118 Kelley KW. Stress and immune function: A bibliographic review. Ann Rech Vet 1980; 11: 445-478
• 119 Webster AC. The adverse effect of environment on the response to distemper vaccination. Aust Vet J 1975; 51: 488-490 DOI: 10.1111/j.1751-0813.1975.tb02388.x.
• 120 Schultz RD. Theory and practice of immunization. In: Kirk RW. Current Veterinary Therapy. Philadelphia, USA: W. B. Saunders Co. Ltd.; 1980: 1248-1255
• 121 Day MJ, Schultz RD. Immunotherapy. In: Day MJ, Schultz RD. Veterinary Immunology – Principles and Practice. 2. Aufl.. Boca Raton, Florida, USA: CRC Press Taylor & Francis Group; 2014: 249-263
• 122 European Advisory Board on Cat Diseases ABCD. ABCD Guidelines on vaccination in immunosuppressed cats. Online im Internet: Accessed March 17, 2022 at: http://www.abcdcatsvets.org/vaccination-of-immunocompromised-cats/
• 123 Bergmann M, Freisl M, Hartmann K. et al. Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane. Vaccines 2020; 8 DOI: 10.3390/vaccines8030547.
• 124 Bergmann M, Freisl M, Hartmann K. et al. Antibody Response to Canine Parvovirus Vaccination in Dogs with Hypothyroidism Treated with Levothyroxine. Vaccines 2021; 9: 180
• 125 Wait LF, Dobson AP, Graham AL. Do parasite infections interfere with immunisation? A review and meta-analysis. Vaccine 2020; 38: 5582-5590 DOI: 10.1016/j.vaccine.2020.06.064.
• 126 Povey RC. Distempter vaccination of dogs: factors which could cause vaccine failure. Can Vet J 1986; 27: 321-323
• 127 European Scientific Counsel ESCCAP. Worm control in dogs and cats. Online im Internet: Accessed May 23, 2022 at: https://www.esccap.org/uploads/docs/oc1bt50t_0778_ESCCAP_GL1_v15_1p.pdf
• 128 Tizard IR. Drugs and other agents that affect the immune system. In: Tizard IR. Veterinary Immunology. 10. Aufl.. St. Louis, Missouri, USA: Elsevier Inc.; 2018: 463-470
• 129 Rinkardt NE, Kruth SA, Kaushik A. The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogs. Can J Vet Res 1999; 63: 18-24
• 130 Ammersbach MA, Kruth SA, Sears W. et al. The effect of glucocorticoids on canine lymphocyte marker expression and apoptosis. J Vet Intern Med 2006; 20: 1166-1171 DOI: 10.1892/0891-6640(2006)20[1166:teogoc]2.0.co;2.
• 131 Nara PL, Krakowka S, Powers TE. Effects of prednisolone on the development of immune responses to canine distemper virus in Beagle pups. Am J Vet Res 1979; 40: 1742-1747
• 132 Blancou J, Milward F, Toma B. Vaccination against rabies in carnivores treated with corticoids. Rec Med Vet 1981; 631-657
• 133 Henry CJ, McCaw DL, Brock KV. et al. Association between cancer chemotherapy and canine distemper virus, canine parvovirus, and rabies virus antibody titers in tumor-bearing dogs. J Am Vet Med Assoc 2001; 219: 1238-1241
• 134 Madewell BR, Theilen GH. Hematopoietic neoplasms, sarcomas and related conditions, in: Part V: Canine. In: Theilen GH, Madewell BR. Veterinary Cancer Medicine. 2. Aufl.. Philadelphia, USA: Lea & Febiger; 1987: 392-407
• 135 Walter CU, Biller BJ, Lana SE. et al. Effects of chemotherapy on immune responses in dogs with cancer. J Vet Intern Med 2006; 20: 342-347 DOI: 10.1892/0891-6640(2006)20[342:eocoir]2.0.co;2.
• 136 Roberts ES, VanLare KA, Roycroft LM. et al. Effect of high-dose ciclosporin on the immune response to primary and booster vaccination in immunocompetent cats. J Feline Med Surg 2015; 17: 101-109 DOI: 10.1177/1098612×14533550.
• 137 Latimer KS, Rakich PM, Purswell BJ. et al. Effects of cyclosporin A administration in cats. Vet Immunol Immunopathol 1986; 11: 161-173
• 138 Mueller RS, Fieseler KV, Bettenay SV. et al. Influence of long-term treatment with tetracycline and niacinamide on antibody production in dogs with discoid lupus erythematosus. Am J Vet Res 2002; 63: 491-494
• 139 Kona-Boun JJ, Silim A, Troncy E. Immunologic aspects of veterinary anesthesia and analgesia. J Am Vet Med Assoc 2005; 226: 355-363
• 140 Kelly GE. The effect of surgery in dogs on the response to concomitant distemper vaccination. Aust Vet J 1980; 56: 556-557 DOI: 10.1111/j.1751-0813.1980.tb02591.x.
• 141 Miyamoto T, Taura Y, Une S. et al. Immunological responses after vaccination pre- and post-surgery in dogs. J Vet Med Sci 1995; 57: 29-32
• 142 Vidor E. The nature and consequences of intra- and inter-vaccine interference. J Comp Pathol 2007; 137: S62-66 DOI: 10.1016/j.jcpa.2007.04.014.
• 143 Greene CE, Decaro N. Canine viral enteritis. In: Greene CE. Infectious Diseases of the Dog and Cat. 4. Aufl.. St. Louis, Missouri, USA: Elsevier Saunders; 2012: 67-75
• 144 Parrish CR, Aquadro CF, Strassheim ML. et al. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol 1991; 65: 6544-6552
• 145 Decaro N, Desario C, Billi M. et al. Western European epidemiological survey for parvovirus and coronavirus infections in dogs. Vet J 2011; 187: 195-199 DOI: 10.1016/j.tvjl.2009.10.027.
• 146 Truyen U. Evolution of canine parvovirus—a need for new vaccines?. Vet Microbiol 2006; 117: 9-13 DOI: 10.1016/j.vetmic.2006.04.003.
• 147 StIKo Vet am FLI. Leitlinie zur Impfung von Kleintieren. 4. Auflage. 2019: 1-53
• 148 Pratelli A, Cavalli A, Martella V. et al. Canine parvovirus (CPV) vaccination: Comparison of neutralizing antibody responses in pups after inoculation with CPV2 or CPV2b modified live virus vaccine. Clin Diagn Lab Immunol 2001; 8: 612-615 DOI: 10.1128/cdli.8.3.612-615.2001.
• 149 Spibey N, Greenwood NM, Sutton D. et al. Canine parvovirus type 2 vaccine protects against virulent challenge with type 2c virus. Vet Microbiol 2008; 128: 48-55 DOI: 10.1016/j.vetmic.2007.09.015.
• 150 Wilson S, Illambas J, Siedek E. et al. Vaccination of dogs with canine parvovirus type 2b (CPV-2b) induces neutralising antibody responses to CPV-2a and CPV-2c. Vaccine 2014; 32: 5420-5424 DOI: 10.1016/j.vaccine.2014.07.102.
• 151 Wilson S, Stirling C, Borowski S. et al. Vaccination of dogs with Duramune DAPPi + LC protects against pathogenic canine parvovirus type 2c challenge. Vet Rec 2013; 172: 662 DOI: 10.1136/vr.101509.
• 152 Von Reitzenstein M, Ludlow D, Marcos S. et al. Cross protection of vanguard 5L4-CV vaccine against virulent canine parvovirus-2c circulating in the USA. Int J Appl Res Vet Med 2012; 10: 187-197
• 153 Hernández-Blanco B, Catala-López F. Are licensed canine parvovirus (CPV2 and CPV2b) vaccines able to elicit protection against CPV2c subtype in puppies?: A systematic review of controlled clinical trials. Vet Microbiol 2015; 180: 1-9 DOI: 10.1016/j.vetmic.2015.07.027.
• 154 Decaro N, Cirone F, Desario C. et al. Severe parvovirus in a 12-year-old dog that had been repeatedly vaccinated. Vet Rec 2009; 164: 593-595
• 155 Decaro N, Desario C, Elia G. et al. Evidence for immunisation failure in vaccinated adult dogs infected with canine parvovirus type 2c. New Microbiol 2008; 31: 125-130
• 156 Sutton D, Vinberg C, Gustafsson A. et al. Canine parvovirus type 2c identified from an outbreak of severe gastroenteritis in a litter in Sweden. Acta Vet Scand 2013; 55: 64 DOI: 10.1186/1751-0147-55-64.
• 157 Cavalli A, Bozzo G, Decaro N. et al. Characterization of a canine parvovirus strain isolated from an adult dog. New Microbiol 2001; 24: 239-242
• 158 Mittal M, Chakravarti S, Mohapatra JK. et al. Molecular typing of canine parvovirus strains circulating from 2008 to 2012 in an organized kennel in India reveals the possibility of vaccination failure. Infect Genet Evol 2014; 23: 1-6 DOI: 10.1016/j.meegid.2014.01.015.
• 159 Miranda C, Thompson G. Canine parvovirus in vaccinated dogs: A field study. Vet Rec 2016; 178: 397 DOI: 10.1136/vr.103508.
• 160 De Oliveira PSB, Cargnelutti JF, Masuda EK. et al. New variants of canine parvovirus in dogs in southern Brazil. Archives of virology 2019; 164: 1361-1369 DOI: 10.1007/s00705-019-04198-w.
• 161 Nandi S, Kumar M, Mohapatra TK. et al. Emergence of canine parvovirus – 2 variants and its impact on vaccination. World Appl Sci J 2013; 23: 1366-1376 DOI: 10.5829/idosi.wasj.2013.23.10.1823.
• 162 Decaro N, Buonavoglia C. Canine parvovirus – a review of epidemiological and diagnostic aspects, with emphasis on type 2c. Vet Microbiol 2012; 155: 1-12 DOI: 10.1016/j.vetmic.2011.09.007.
• 163 Kapil S, Cooper E. Vaccines containing canine parvovirus genetic variants. Online im Internet Accessed August 28, 2019 at: https://patentsgooglecom/patent/WO2008157236A1
• 164 Wang J, Lin P, Zhao H. et al. Continuing evolution of canine parvovirus in China: Isolation of novel variants with an Ala5Gly mutation in the VP2 protein. Infect Genet Evol 2016; 38: 73-78 DOI: 10.1016/j.meegid.2015.12.009.
• 165 Decaro N, Desario C, Elia G. et al. Occurrence of severe gastroenteritis in pups after canine parvovirus vaccine administration: A clinical and laboratory diagnostic dilemma. Vaccine 2007; 25: 1161-1166 DOI: 10.1016/j.vaccine.2006.10.020.
• 166 StIKo Vet am FLI. Empfehlungen zur guten Impfpraxis in der Veterinärmedizin. 2018: 1-18
• 167 Spiess H, Heininger U. Versagensursachen von Schutzimpfungen. In: Spiess H, Heininger U. Impfkompendium. 6. Aufl.. Stuttgart, Deutschland: Georg Thieme Verlag KG; 2005: 119-120
• 168 Hustead DR. What you can and cannot learn from reading a vaccine label. Vet Clin North Am Small Anim Pract 2001; 31: 539-556 DOI: 10.1016/S0195–5616(01)50608–7.
• 169 Bergmann M, Freisl M, Hartmann K . [. Prevention of canine parvovirosis – Part 3: Vaccine-associated adverse events. ]. Tierarztl Prax Ausg K 2021; 49: 294-299 DOI: 10.1055/a-1543-4632.
• 170 Povey RC, Carman PS. Routes of vaccination. In: Pastoret PP, Blancou J, Vannier P. et al Veterinary Vaccinology. Amsterdam, Niederlande: Elsevier Science B. V.; 1997: 525-528
• 171 Siegrist CA. Mechanisms underlying adverse reactions to vaccines. J Comp Pathol 2007; 137: 46-50 DOI: 10.1016/j.jcpa.2007.04.012.
• 172 Bergmann M, Freisl M, Hartmann K. [Prophylaxis of canine parvovirosis – Part 2: Vaccines]. Tierarztl Prax Ausg K 2021; 49: 122-125 DOI: 10.1055/a-1402-9476.